American Society of Clinical Oncology statement: A conceptual framework to assess the value of cancer treatment options Journal Article

   

Authors:	Schnipper, L. E.; Davidson, N. E.; Wollins, D. S.; Tyne, C.; Blayney, D. W.; Blum, D.; Dicker, A. P.; Ganz, P. A.; Hoverman, J. R.; Langdon, R.; Lyman, G. H.; Meropol, N. J.; Mulvey, T.; Newcomer, L.; Peppercorn, J.; Polite, B.; Raghavan, D.; Rossi, G.; Saltz, L.; Schrag, D.; Smith, T. J.; Yu, P. P.; Hudis, C. A.; Schilsky, R. L.
Article Title:	American Society of Clinical Oncology statement: A conceptual framework to assess the value of cancer treatment options
Keywords:	prednisone; chemotherapy; prostate-cancer; cell lung-cancer; multiple-myeloma; care; her2-positive breast-cancer; open-label; increased survival; top 5 list; plus adjuvant
Journal Title:	Journal of Clinical Oncology
Volume:	33
Issue:	23
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2015-08-10
Start Page:	2563
End Page:	2577
Language:	English
ACCESSION:	WOS:000361654600013
DOI:	10.1200/jco.2015.61.6706
PROVIDER:	wos
PUBMED:	26101248
PMCID:	PMC5015427
Notes:	Article -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/82517